Literature DB >> 23668538

Modern vitiligo genetics sheds new light on an ancient disease.

Richard A Spritz1.   

Abstract

Vitiligo is a complex disorder in which autoimmune destruction of melanocytes results in white patches of skin and overlying hair. Over the past several years, extensive genetic studies have outlined a biological framework of vitiligo pathobiology that underscores its relationship to other autoimmune diseases. This biological framework offers insight into both vitiligo pathogenesis and perhaps avenues towards more effective approaches to treatment and even disease prevention.
© 2013 Japanese Dermatological Association.

Entities:  

Mesh：

Year:  2013        PMID： 23668538      PMCID： PMC3783942          DOI： 10.1111/1346-8138.12147

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


  109 in total

1.  Linkage and association of HLA class II genes with vitiligo in a Dutch population.

Authors:  M Zamani; M Spaepen; S S Sghar; C Huang; W Westerhof; L Nieuweboer-Krobotova; J J Cassiman
Journal:  Br J Dermatol       Date:  2001-07       Impact factor: 9.302

2.  Epidemiology of vitiligo in the French West Indies (Isle of Martinique).

Authors:  A M Boisseau-Garsaud; P Garsaud; D Calès-Quist; R Hélénon; C Quénéhervé; R C Claire
Journal:  Int J Dermatol       Date:  2000-01       Impact factor: 2.736

3.  Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2.

Authors:  Asem Alkhateeb; Gary L Stetler; William Old; Janet Talbert; Cynthia Uhlhorn; Melanie Taylor; Angela Fox; Cynthia Miller; Diana G Dills; E Chester Ridgway; Dorothy C Bennett; Pamela R Fain; Richard A Spritz
Journal:  Hum Mol Genet       Date:  2002-03-15       Impact factor: 6.150

4.  Vitiligo is not caused by mutations in GTP-cyclohydrolase I gene.

Authors:  D Bandyopadhyay; E Lawrence; P P Majumder; R E Ferrell
Journal:  Clin Exp Dermatol       Date:  2000-03       Impact factor: 3.470

5.  Analysis of a microsatellite polymorphism of the cytotoxic T-lymphocyte antigen-4 gene in patients with vitiligo.

Authors:  E H Kemp; R A Ajjan; E A Waterman; D J Gawkrodger; M J Cork; P F Watson; A P Weetman
Journal:  Br J Dermatol       Date:  1999-01       Impact factor: 9.302

6.  Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus.

Authors:  S K Nath; J A Kelly; B Namjou; T Lam; G R Bruner; R H Scofield; C E Aston; J B Harley
Journal:  Am J Hum Genet       Date:  2001-10-08       Impact factor: 11.025

7.  Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation.

Authors:  R K Tripathi; D J Flanders; T L Young; W S Oetting; A Ramaiah; R A King; R E Boissy; J J Nordlund
Journal:  Pigment Cell Res       Date:  1999-06

8.  'VIT1', a novel gene associated with vitiligo.

Authors:  I C Le Poole; R Sarangarajan; Y Zhao; L S Stennett; T L Brown; P Sheth; T Miki; R E Boissy
Journal:  Pigment Cell Res       Date:  2001-12

9.  Familial aggregation of vitiligo in the French West Indies (Isle of Martinique).

Authors:  A M Boisseau-Garsaud; I Saint-Cyr; D Quist; B Arveiler; P Garsaud
Journal:  Eur J Dermatol       Date:  2001 Nov-Dec       Impact factor: 3.328

Review 10.  A comprehensive review of genetic association studies.

Authors:  Joel N Hirschhorn; Kirk Lohmueller; Edward Byrne; Kurt Hirschhorn
Journal:  Genet Med       Date:  2002 Mar-Apr       Impact factor: 8.822
View more
  26 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  Major association of vitiligo with HLA-A*02:01 in Japanese.

Authors:  Ying Jin; Masahiro Hayashi; Pamela R Fain; Tamio Suzuki; Kazuyoshi Fukai; Naoki Oiso; Atsushi Tanemura; Cherie L Holcomb; Melinda Rastrou; Henry A Erlich; Richard A Spritz
Journal:  Pigment Cell Melanoma Res       Date:  2015-02-17       Impact factor: 4.693

3.  The role of the Th1 chemokine CXCL10 in vitiligo.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Poupak Fallahi
Journal:  Ann Transl Med       Date:  2015-05

Review 4.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

5.  Narrow Band Ultraviolet B Treatment for Human Vitiligo Is Associated with Proliferation, Migration, and Differentiation of Melanocyte Precursors.

Authors:  Nathaniel B Goldstein; Maranke I Koster; Laura G Hoaglin; Nicole S Spoelstra; Katerina J Kechris; Steven E Robinson; William A Robinson; Dennis R Roop; David A Norris; Stanca A Birlea
Journal:  J Invest Dermatol       Date:  2015-03-30       Impact factor: 8.551

6.  [Vitiligo: Clinical presentation and pathogenesis].

Authors:  M Schild; M Meurer
Journal:  Hautarzt       Date:  2016-02       Impact factor: 0.751

Review 7.  Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo.

Authors:  John E Harris
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

8.  Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection.

Authors:  Nathaniel B Goldstein; Maranke I Koster; Laura G Hoaglin; Michael J Wright; Steven E Robinson; William A Robinson; Dennis R Roop; David A Norris; Stanca A Birlea
Journal:  Exp Dermatol       Date:  2016-10       Impact factor: 3.960

Review 9.  Innate immune mechanisms in vitiligo: danger from within.

Authors:  Jillian M Richmond; Michael L Frisoli; John E Harris
Journal:  Curr Opin Immunol       Date:  2013-11-12       Impact factor: 7.486

Review 10.  Pigmentation and vision: Is GPR143 in control?

Authors:  Brian S McKay
Journal:  J Neurosci Res       Date:  2018-05-14       Impact factor: 4.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.